Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03298516
Title A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of Colorado Hospital - Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
Yale School of Medicine New Haven Connecticut 06510 United States Details
Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 New York New York 10032 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Alberta Hospital Edmonton Alberta T6G 1C9 Canada Details
Princess Margaret Hospital; Department of Med Oncology Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital / McGill University Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field